Einar Bogason, MD
Neurological Surgery · Des Moines, IANPI 1881823052
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.0%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Alphatec Spine, Inc at 45.0% of the total. Reporting peaked in 2021 at $2,201 and has fallen 74.0% since, to $571 in 2025.
Across 62 payments — averaging $69.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alphatec Spine, Inc$2K
- Medtronic$345
- Johnson & Johnson$286
- Irras USA, Inc.$275
- Imperative Care, Inc$216
- Stryker$180
- plus $1K from 18 others
What the payments were for
- Speaking & faculty fees$2756%
- Travel & lodging$1,80642%
- Food & beverage$2,25452%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alphatec Spine, Inc | 7 | $1,950 |
| Medtronic(2 entities) | 7 | $345 |
| Johnson & Johnson | 5 | $286 |
| Irras USA, Inc. | 1 | $275 |
| Imperative Care, Inc | 3 | $216 |
| Stryker | 3 | $180 |
| Abbott | 10 | $176 |
| Baxter Healthcare | 3 | $172 |
| Globus Medical | 1 | $147 |
| AbbVie | 4 | $104 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $78 |
| AstraZeneca(2 entities) | 3 | $76 |
| Si-bone, Inc. | 1 | $63 |
| KARL Storz Endoscopy-america | 1 | $61 |
| Eisai Inc. | 1 | $30 |
| Jazz Pharmaceuticals Inc. | 1 | $27 |
| Merz Pharmaceuticals, LLC | 1 | $26 |
| Silk Road Medical, Inc. | 1 | $23 |
| Integra Lifesciences Corporation | 1 | $23 |
| Lilly USA, LLC | 1 | $21 |
| Asahi Intecc USA, Inc. | 1 | $16 |
| Inspire Medical Systems, Inc. | 1 | $14 |
| Kerecis Limited | 1 | $13 |
| Neurocrine Biosciences, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Other - Miscellaneous$498
- IRRAflow$275
- ZOOM 88-T LARGE DISTAL PLATFORM$162
- Excelsius - GPS$147
- SafeOp$143
- VIPER$130
- EXCELSIOR SL-10$106
- SURPASS EVOLVE$106
How this compares
$4,335 in reported general payments places this provider in the 75th percentile of 54 neurological surgery providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 13 | $183 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $65 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Des Moines
- Timothy RykenDes Moines$44K
- Nicholas WetjenDes Moines$23K
- Troy MunsonDes Moines$15K
- Zoya VoronovichDes Moines$11K
- Royce WoodroffeDes Moines$8K
- Scott SeamanDes Moines$3K
- Esmiralda Yeremeyeva HendersonDes Moines$2K
- Joseph SherrillDes Moines$2K
- David BoariniDes Moines$638
- John PiperDes Moines$508
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.